Aug 092018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– SWITZERLAND, Basel – Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced it has completed a $60 million mezzanine financing led by Novo Holdings and joined by new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management LLC.… => Read full post

Therachon adds Dr Jørgen Petersen and Tim Anderson to Board along with a $60m mezzanine financing led by Novo Holdings

From:: Therachon adds Dr Jørgen Petersen and Tim Anderson to Board along with a $60m mezzanine financing led by Novo Holdings

Sorry, the comment form is closed at this time.

%d bloggers like this: